Literature DB >> 23203841

Dynamic changes of cerebral-specific proteins in full-term newborns with hypoxic-ischemic encephalopathy.

Fang Liu1, Suyan Yang, Zhifang Du, Zhimei Guo.   

Abstract

The aim of this study was to observe the dynamic changes of serum brain-derived neurotrophic factor (BDNF), S-100B, and Tau proteins levels in full-term newborns with hypoxic-ischemic encephalopathy (HIE) and to discuss their significance in brain damage. Serum samples of 28 full-term newborns diagnosed with HIE and 20 controls were obtained in the first 24 h of life. Another serum samples were also taken, respectively, at 3 and 7 days of life in HIE group. The concentrations of BDNF, S-100B, and Tau proteins were measured by the enzyme-linked immunosorbent assay method. Mean concentrations of BDNF, S-100B, and Tau proteins among different time period and in different grades of HIE group were calculated and compared. Compared with the control group, serum BDNF and proteins S-100B levels in HIE group were significantly elevated in 24 h after birth (P < 0.05) and their concentrations were also significantly higher among patients with mod-severe HIE compared to those with mild HIE at 24 h and 7 days after asphyxia (P < 0.05). Regardless of whether mod-severe HIE or mild HIE, there were no significant difference of serum BDNF and proteins S-100B among the three different time periods. There was no difference in Tau protein levels between HIE group and control group, also no difference between mod-severe HIE group and mild HIE group. BDNF and proteins S-100B are up-regulated early in asphyxia neonates with HIE; and the released amount of BDNF and proteins S-100B from nerve center system correlate with the extent of encephalopathy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23203841     DOI: 10.1007/s12013-012-9478-3

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  5 in total

1.  Angiogenesis dysregulation in term asphyxiated newborns treated with hypothermia.

Authors:  Henna Shaikh; Elodie Boudes; Zehra Khoja; Michael Shevell; Pia Wintermark
Journal:  PLoS One       Date:  2015-05-21       Impact factor: 3.240

2.  Tau protein as a biomarker for asphyxia: A possible forensic tool?

Authors:  Mohamed Salama; Wael M Y Mohamed
Journal:  Appl Transl Genom       Date:  2016-03-03

3.  SBDPs and Tau proteins for diagnosis and hypothermia therapy in neonatal hypoxic ischemic encephalopathy.

Authors:  Hongwei Wu; Zhenguang Li; Xia Yang; Jinfeng Liu; Wei Wang; Gang Liu
Journal:  Exp Ther Med       Date:  2016-11-18       Impact factor: 2.447

4.  Epidermal Growth Factor Receptor Inhibition Reverses Cellular and Transcriptomic Alterations Induced by Hypoxia in the Neonatal Piglet Brain.

Authors:  Panagiotis Kratimenos; Evan Z Goldstein; Ioannis Koutroulis; Susan Knoblach; Beata Jablonska; Payal Banerjee; Shadi N Malaeb; Surajit Bhattacharya; M Isabel Almira-Suarez; Vittorio Gallo; Maria Delivoria-Papadopoulos
Journal:  iScience       Date:  2020-11-04

5.  Therapeutic Hypothermia Modulates the Relationships Between Indicators of Severity of Neonatal Hypoxic Ischemic Encephalopathy and Serum Biomarkers.

Authors:  Raul Chavez-Valdez; Sarah Miller; Harisa Spahic; Dhananjay Vaidya; Charlamaine Parkinson; Barbara Dietrick; Sandra Brooks; Gwendolyn J Gerner; Aylin Tekes; Ernest M Graham; Frances J Northington; Allen D Everett
Journal:  Front Neurol       Date:  2021-11-02       Impact factor: 4.086

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.